acetylcholinesterase compounds (Promentis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameacetylcholinesterase compounds (Promentis)
Drug Alias Nameacetylcholinesterase compounds (Montana University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsNerve DegenerationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Montana
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPromentis Pharmaceuticals IncUniversity Of Montana
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A